Amorphous silica
Based on 1 Customer Validation
Amorphous silica can be used as an excipient, such as viscosifier, suspending agent, tablet disintegrating agent, adsorbent dispersing agent as liquid in powders. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs.
For research use only. We do not sell to patients.
- Purity : 99.96%
- CAS No.: 112945-52-5
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-104035E
Dimethyl silicone oil, viscosity 100 cSt (25 °C)Biochemical Reagent -
HY-W051271
Titanium(IV) oxidePhotocatalyst -
HY-Y0498
Aluminum oxideAdjuvant -
HY-W088074A
Chromium(III)oxide, 99.9% trace metals basisBiochemical Assay Reagent -
HY-Y1213
CarbonPharmaceutical Excipient -
HY-W115786
KaolinKaolinitic Clay -
HY-W116336B
Zinc oxide, 99.99% metals basisBiochemical Assay Reagents -
HY-W116336D
Zinc oxide, <100 nm particle sizeNitrate Reductase Activator -
HY-104035H
Dimethyl silicone oil, viscosity 10 cSt (25 °C)Biochemical Reagent
Biological Activity
Description
Chemical Information
-
CAS No. 112945-52-5
-
Appearance Solid
-
Color White to off-white
-
SMILES
[Amorphous silica]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Protocols
-
Protocol for Pharmacokinetic Study
Pharmacokinetic studies quantify how an organism handles a drug over time through absorption, distribution, metabolism, and excretion, and the core experimental readout is the concentration-time profile of parent drug and, when relevant, metabolites in biological matrices such as plasma, whole blood, urine, bile, or tissue. Pharmacokinetic analysis links dose, route, exposure, clearance, half-life, distribution, bioavailability, and systemic exposure to drug efficacy and toxicity hypotheses rather than measuring a signaling pathway directly. The literature links pharmacokinetics to drug-development phenotypes by showing that drug metabolism and pharmacokinetics influence compound progression, exposure-response interpretation, safety margins, dosing strategy, and failure risk during discovery and development. DMPK science contributes to compound optimization by integrating physicochemical properties, in vitro metabolism, transporter behavior, in vivo exposure, and pharmacodynamic contex
Purity & Documentation
-
Data Sheet (264 KB)
-
SDS (419 KB)
- English - EN (419 KB)
- Français - FR (419 KB)
- Deutsch - DE (419 KB)
- Norwegian - NO (419 KB)
- Español - ES (419 KB)
- Swedish - SV (419 KB)
- Italian - IT (419 KB)
- Korean - KR (419 KB)
- Portuguese - PT (419 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Amorphous silica Related Classifications
HY-154739A Related Classifications
Powered by Bioz